No Data
APT Medical's (SHSE:688617) Profits Appear To Have Quality Issues
We Ran A Stock Scan For Earnings Growth And APT Medical (SHSE:688617) Passed With Ease
The Deputy General Manager of APT Medical Inc. (688617.SH), Han Yonggui, completed a Shareholding of 0.0299 million shares.
APT Medical Inc. (688617.SH) announced that the company's vice president Han Yonggui has reduced his shareholding through centralized bidding Trade...
Direct coverage of the Star medical instruments industry collective Earnings Conference: Multiple companies are laying out AI medical Business, and key segments in innovation fields may accelerate the development of domestic production.
① Attending companies believe that tariff policies will bring some cost pressures and market challenges to enterprises, but at the same time, it has accelerated the localization process in relevant fields; ② Some attending companies disclosed the latest developments in their Business during the earnings briefing and the planning for related lines by 2025.
APT Medical's 2024 Profit Rises 26%, Operating Income Climbs 25%; Shares Drop 4%
Huitai Healthcare: 2024 Annual Report Summary
If EPS Growth Is Important To You, APT Medical (SHSE:688617) Presents An Opportunity
